US generic drugmaker Perrigo has agreed to buy Irish firm Elan for just under 6.5 billion euros. <br /><br />The deal gives it tax savings from being domiciled in Ireland.<br /><br />By moving its headquarters, Perrigo can take advantage of the very low 12.5 percent corporate tax rate in Ireland compared with 35 percent in the United States.<br /><br />...<br />http://www.euronews.net/
